NovaSterilis is committed to providing supercritical CO2 technologies that meet or exceed the highest standards for product safety and performance. We are focused on the continued development of new applications of environmentally friendly supercritical CO2 through a deeper understanding of the chemical properties and engineering of equipment to meet the demands of each opportunity.
Supercritical CO2, combined with extremely low volumes of our proprietary NovaKillTM sterilization additive, provides the biomedical community with an alternative to gamma irradiation and ethylene oxide for terminal product sterilization. NovaSterilis achieves sterilization without compromising the integrity of many products. We have developed protocols and performed countless experiments specifically designed to prove the NovaSterilis process achieves a Sterility Assurance Level of 10-6 (SAL6) while preserving the characteristics of delicate devices, biomedical materials, and allograft tissue. We are authorized to commercialize and sell this technology to various industries including tissue bank processors.